Drug Expenditure, Price, and Utilization in US Medicaid: A Trend Analysis for New Multiple Myeloma Medications from 2016 to 2022.

Marwan Alrasheed,Abdulrahman Alsuhibani,Bander Balkhi,Jeff Jianfei Guo

Healthcare (Basel, Switzerland)（2023）

引用 0|浏览3

暂无评分

摘要

The results of this study demonstrate that CMS utilization and spending on MM medications have significantly grown since 2016. Daratumumab has by far the highest utilization, spending, and market share. The utilization of and spending on specific pharmaceuticals are clearly impacted by policy and clinical guideline recommendations.

查看译文

关键词

Medicaid,drug expenditure,drug utilization,multiple myeloma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要